AstraZeneca AG

Non-Quoted Public Company
Grafenau 10, Zug,  CH-6301, Switzerland
()41 041 725 75 75, 41 041 725 76 76 fax, http://www.astrazeneca.ch

Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Marketing and distribution of pharmaceutical products

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

AstraZeneca AG, News and Information

Pharmaceutical Industry in Sweden - Includes Data on Market Size and Segmentation, Key Trends and Competitive Landscape, Leading Companies & Much More.
M2 Presswire; 11/5/2009; 854 words; ...Industry F. Leading Players in the Market F.1 AstraZeneca Plc F.2 Pfizer Inc F.3 Novartis AG G. Appendix G.1 Offshoring in the Pharmaceutical...Companies Mentioned: - Pfizer Inc - Novartis AG - AstraZeneca Plc For more information visit http://www...

Research and Markets: Pharmaceutical Industry in Sweden - Includes Data on Market Size and Segmentation, Key Trends and Competitive Landscape, Leading Companies & Much More.
Business Wire; 11/5/2009; 992 words; ...Industry F. Leading Players in the Market F.1 AstraZeneca Plc F.2 Pfizer Inc F.3 Novartis AG G. Appendix G.1 Offshoring in the Pharmaceutical...Companies Mentioned: * Pfizer Inc * Novartis AG * AstraZeneca Plc For more information visit http://www...

Seattle Genetics Highlights Pipeline Progress and Reports Third Quarter 2009 Financial Results.(Financial report)
Blood Weekly; 11/5/2009; 2227 words; ...agreement with MedImmune, LLC, a wholly owned subsidiary of AstraZeneca, triggered by its initiation of a phase I clinical trial of...milestone payment under collaboration with Bayer Schering Pharma AG, Germany, triggered by Bayer's submission of an IND application...

Genentech's Avastin Phase III Misses Breast Cancer Endpoint.
BIOWORLD Today; 11/4/2009; 1304 words; ...suffered fallout from the failure of Iressa, London-based AstraZeneca plc's EGFR inhibitor for cancer. (See BioWorld Today...partnered with Basel, Switzerland-based Novartis Pharma AG, by the end of the year. Lowering Genentech's rating from...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2158 words; ...collaboration between the Institute of Cancer Research in Sutton, UK; AstraZeneca plc, of London; and BTG. o Endo Pharmaceuticals Holdings...for later this year. The product is partnered with Schering AG, of Berlin. EPIX's shares (NASDAQ:EPIX) gained $4...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.